Why This Crypto Bull Won’t Touch Dogecoin

One crypto expert is sitting out the rally in dogecoin, and says the meme coin is in a mania.

Dogecoin has had a wild year.

The cryptocurrency started as a joke in 2013 is up 6,287% since the beginning of 2021, hitting a new all-time high of $0.45 on Wednesday.

So what sparked the rally? Dallas Mavericks owner Mark Cuban said the coin is a better investment than a lottery ticket on an appearance at the Ellen DeGeneres show and Tesla CEO Elon Musk teased his upcoming stint as the host of Saturday Night Live with a tweet that read, “The Dogefather SNL May 8.”

But it’s Dogecoin’s meteoric rise this year that one crypto bull is calling a mania, and with Wednesday’s catalysts, it’s hard to argue that.

Meltem Demirors, chief strategy officer at CoinShares, said this week that there’s a good reason her firm has steered clear of the meme-coin.

“It’s a classic sort of bubble, in my view,” Demirors said. “I’m not saying it’s good or bad. …Dogecoin is not for me. My firm does not produce analysis on dogecoin for a reason. We don’t have a dogecoin ETF in the market. We don’t trade dogecoin.”

“At the end of the day, we have these retail manias, and I think what’s happening with dogecoin is definitely a mania and we see this reflected in the price,” Demirors continued, adding that the rise in dogecoin shows some people that “investing is entertainment.”

Demirors isn’t the only crypto bull sitting out dogecoin. Galaxy Digital CEO Mike Novogratz said recently that what is happening with dogecoin is “even more bizarre” than what happened with GameStop (NYSE: GME) in February. 

“Dogecoin speaks to a lot of the same movement that GameStop did,” Novogratz said. “There is a crazy excitement [from] very young investors around meme coins and meme ideas. I mean, it’s shocking to me that GameStop continues to hold any value. Dogecoin is even more bizarre in that respect.”

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More